BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 104144)

  • 1. Enzymatic fragmentation of tetanus toxin. Identification and characterization of an atoxic, immunogenic fragment.
    Robinson JP; Chen HC; Hash JH; Puett D
    Mol Cell Biochem; 1978 Oct; 21(1):23-31. PubMed ID: 104144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A candidate carrier protein for beta-human chorionic gonadotropin: 54,000-molecular-weight fragment of tetanus toxin.
    Covey DC; Moore DE; Chang CC; Laurence KA
    Am J Reprod Immunol Microbiol; 1985 Jun; 8(2):43-7. PubMed ID: 2411156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments.
    Helting TB; Zwisler O
    J Biol Chem; 1977 Jan; 252(1):187-93. PubMed ID: 401808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the immune response to papain digestion products of tetanus toxin.
    Helting TB; Nau HH
    Acta Pathol Microbiol Immunol Scand C; 1984 Feb; 92(1):59-63. PubMed ID: 6711309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetanus toxin. The effect of chemical modifications on toxicity, immunogenicity, and conformation.
    Robinson JP; Picklesimer JB; Puett D
    J Biol Chem; 1975 Sep; 250(18):7435-42. PubMed ID: 809435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on immune response to atoxic fragments of tetanus toxin and its denatured antigen.
    Chiba K
    Kitasato Arch Exp Med; 1982 Dec; 55(3-4):79-118. PubMed ID: 7186080
    [No Abstract]   [Full Text] [Related]  

  • 7. Enzymatic hydrolysis of tetanus toxin by intrinsic and extrinsic proteases. Characterization of the fragments by monoclonal antibodies.
    Goretzki K; Habermann E
    Med Microbiol Immunol; 1985; 174(3):139-50. PubMed ID: 3897815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gene cloning, optimized expression and immunogenicity evaluation of tetanus toxin fragment C].
    Wang MY; Zhang YN; Lei M; Zuo DM; Zhang LY; Chen ZL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):731-5. PubMed ID: 18504192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An antigenic polypeptide fragment isolated from tetanus toxin: chemical characterization, binding to gangliosides and retrograde axonal transport in various neuron systems.
    Bizzini B; Stoeckel K; Schwab M
    J Neurochem; 1977 Mar; 28(3):529-42. PubMed ID: 67185
    [No Abstract]   [Full Text] [Related]  

  • 10. Conformational and molecular weight studies of tetanus toxin and its major peptides.
    Robinson JP; Holladay LA; Hash JH; Puett D
    J Biol Chem; 1982 Jan; 257(1):407-11. PubMed ID: 7031063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simplified method for the preparation of tetanus toxin binding fragment for neurobiology.
    Fishman PS; Farrand DA; Halpern JL; Latham WC
    J Neurosci Methods; 1992 May; 42(3):229-36. PubMed ID: 1380109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation, purification, and characterization of fragment B, the NH2-terminal half of the heavy chain of tetanus toxin.
    Matsuda M; Lei DL; Sugimoto N; Ozutsumi K; Okabe T
    Infect Immun; 1989 Nov; 57(11):3588-93. PubMed ID: 2478476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcutaneous delivery of tetanus toxin Hc fragment induces superior tetanus toxin neutralizing antibody response compared to tetanus toxoid.
    Johnston L; Mawas F; Tierney R; Qazi O; Fairweather N; Sesardic D
    Hum Vaccin; 2009 Apr; 5(4):230-6. PubMed ID: 18948742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines.
    Qazi O; Sesardic D; Tierney R; Söderbäck Z; Crane D; Bolgiano B; Fairweather N
    Infect Immun; 2006 Aug; 74(8):4884-91. PubMed ID: 16861677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the antigenic structure of tetanus toxin.
    Bizzini B; Raynaud M
    Ann Immunol (Paris); 1975; 126(2):159-76. PubMed ID: 53028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and purification of two antigenically active, "complimentary" polypeptide fragments of tetanus neurotoxin.
    Matsuda M; Yoneda M
    Infect Immun; 1975 Nov; 12(5):1147-53. PubMed ID: 1104484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and purification by high performance liquid chromatography of a tetanus toxin fragment (fragment [A-B]) derived from mildly papain-treated toxin.
    Ozutsumi K; Lei DL; Sugimoto N; Matsuda M
    Toxicon; 1989; 27(9):1055-7. PubMed ID: 2799836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope repertoire of human CD4+ lines propagated with tetanus toxoid or with synthetic tetanus toxin sequences.
    Raju R; Diethelm-Okita B; Okita D; Conti-Fine BM
    J Autoimmun; 1996 Feb; 9(1):79-88. PubMed ID: 8845057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the antibody composition and neutralizing activity of tetanus antitoxin sera from various species of animals in relation to the antigenic substructure of the tetanus toxin molecule.
    Matsuda M; Makinaga G; Hirai T
    Biken J; 1983 Dec; 26(4):133-43. PubMed ID: 6204634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies against tetanus toxin and toxoid.
    Ahnert-Hilger G; Bizzini B; Goretzki K; Müller H; Völckers C; Habermann E
    Med Microbiol Immunol; 1983; 172(2):123-35. PubMed ID: 6193402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.